Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-01 Cream Photoallergy Potential in Healthy Subjects
NCT03899064Phase 1Completed
- Sponsor
- MC2 Therapeutics
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of calcipotriol + betamethasone in plaque psoriasis (9 arms), sponsored by MC2 Therapeutics. Primary endpoint: Overall Numeric Rating of Erythema and Edema at 72 hours. Started Feb 2019; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03899064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899064.